FTO Genotype (rs9939609)

Some people seem to gain weight more easily than others, even when they eat and move in similar ways. A small piece of that puzzle sits in your DNA, and this test reads the single most studied genetic clue: a variant in your FTO gene called rs9939609.

Knowing your result will not tell you whether you are obese today. It tells you whether your biology nudges you toward eating more, storing more fat, and carrying a higher long-term risk of type 2 diabetes and heart disease, so you can decide how aggressively to act on diet, sleep, and activity before those risks become a diagnosis.

What This Test Actually Reads

Your FTO (fat mass and obesity-associated) gene sits on chromosome 16 and helps regulate how your body controls appetite and fat cell behavior. The rs9939609 variant is a single letter change in this gene's DNA code. You inherit one copy from each parent, so your result will be one of three combinations: TT, AT, or AA. The A version is the risk version. TT carries the lowest tendency toward weight gain, AT sits in the middle, and AA carries the highest.

The biology is more layered than the gene name suggests. The variant sits in an intron of FTO, but landmark functional studies have shown it acts largely by changing the activity of two neighboring genes, IRX3 and IRX5, that sit hundreds of thousands of bases away. Disrupting a regulatory region around rs9939609 (and the closely linked rs1421085) tips adipocyte precursors away from energy-burning beige fat toward energy-storing white fat. FTO itself also contributes through appetite signaling in the brain. Both mechanisms feed into the same end result: a greater tendency to gain and store fat.

Because this is a fixed DNA sequence, the result does not change over your lifetime. One accurate test gives you the answer for good.

Body Weight and Body Fat

The clearest signal from this variant is on body weight and body fat. Across pooled analyses of more than 177,000 adults, each A allele adds about 0.3 to 0.4 kg/m² to BMI, roughly 1 kg of body weight per copy. People carrying the A allele tend to weigh more, carry more fat, and have a higher chance of obesity.

Sources: Eghbali et al. meta-analysis 2026; Park and Choi 2023; Agagunduz and Gezmen-Karadag 2019.

What this means for you: a positive A result does not lock in extra weight, but it does mean your baseline biology is working against you slightly. Many of the people studied still maintained healthy weights through their diet and activity patterns, which is the actionable takeaway.

Why It Matters: Type 2 Diabetes

FTO risk-allele carriers face a higher chance of developing type 2 diabetes, partly through weight gain and partly through direct effects on glucose control. In a study of 1,381 Chinese Han adults, A allele carriers had a higher risk of both type 2 diabetes and dyslipidemia, and the risk climbed further in those with obesity.

A larger study following 12,254 adults found that the FTO risk allele combined with prolonged eating windows, late meal timing, and poor sleep quality produced a sharply higher chance of type 2 diabetes. Carriers with disciplined eating windows and good sleep did not see the same risk climb, which suggests this is one of the more controllable genetic risks once you know about it.

Why It Matters: Heart Disease

A meta-analysis of FTO rs9939609 and cardiovascular disease found that the A allele was associated with about 18% higher odds of cardiovascular disease, with the relationship persisting after BMI adjustment in several analyses. The pooled studies showed substantial heterogeneity, and whether this BMI-independent effect holds up uniformly across populations is still debated. In a separate Finnish cohort followed long-term, AA carriers had a higher chance of cardiovascular disease and related death than TT carriers, independent of traditional risk factors like cholesterol and blood pressure.

The practical read: this variant adds incremental information beyond a standard lipid panel. It is one reason that two people with identical cholesterol numbers can have meaningfully different lifetime heart risk.

Why It Matters: Metabolic Syndrome and Lipids

In two rural communities in northeast India, people with the AA genotype had significantly higher odds of metabolic syndrome compared to TT carriers. In a study of 380 adult women, the A allele was associated with lower HDL cholesterol, the protective form of cholesterol. A separate study in 196 overweight adults confirmed lower HDL alongside higher leptin in A-allele carriers.

How the Variant Affects Your Biology

The A version of FTO seems to influence weight mainly through appetite and food choice. In a study of 2,823 children, A-allele carriers consumed more energy from food than non-carriers, independent of their body weight. They were not burning fewer calories. They were eating more.

In 384 Thai adults, A-allele carriers ate more sugar and more saturated fat than non-carriers, and also showed higher leptin, a hormone that normally signals fullness. At the fat cell level, the risk genotype is linked to changes in how fat cells release stored energy, which may help explain the body composition differences across populations.

Who Is Most Affected

The effect of rs9939609 is not the same in everyone. Sex and age matter. In the Korean cohort, the association with body composition was clearest in women under 50. In a Polish study of 1,097 adults, the association ran the other way: men carrying the A allele had higher body weight, BMI, and waist-to-hip ratio, while women did not. In Chinese children, the association with BMI and obesity did not appear until ages 12 to 14, and became stronger through adolescence.

This is not a contradiction. It reflects how a genetic tendency interacts with hormones, life stage, and environment. The variant tilts the scales. Your context decides how much that tilt actually moves the number.

Reconciling a Genetic Risk With Lifestyle Power

A natural question: if I have the A allele, am I stuck? The evidence says no. The strongest analysis to date, an individual-participant meta-analysis pooling 9,563 people from eight randomized controlled trials, found that the FTO variant did not significantly affect how much weight people lost in response to diet, exercise, or drug interventions. People with the risk allele lost weight at the same rate as people without it.

A separate, smaller meta-analysis of diet and lifestyle programs hinted that AA carriers may even lose slightly more weight than TT carriers, on the order of 0.4 kg more on average. That observation is in mild tension with the larger BMJ analysis and is best treated as a secondary signal. The consistent message across the better-powered evidence is that the gene does not block your response to lifestyle changes. It mainly raises your starting risk.

Tracking Your Trend and Companion Tests

Because rs9939609 is a fixed inherited variant, you only need to test it once. There is nothing to retest, no biological variation to average across samples, and no medication that changes the result. The number you get is for life.

What does need ongoing tracking is the biology your variant influences. A meaningful workup paired with this result includes:

• Body composition and waist circumference: measured at least annually, since the A allele is most directly linked to fat accumulation.
• Fasting glucose, HbA1c, and fasting insulin: to catch early shifts in glucose handling, especially relevant if you carry the A allele and have other risk factors.
• A full lipid panel including HDL, ApoB, and ideally Lp(a): to see whether the cardiovascular risk associated with this variant is showing up in your blood numbers.
• Leptin: elevated in A-allele carriers in multiple studies, useful as a window on appetite-regulation biology.

What to Do With an At-Risk Result

If your result comes back AT or AA, the decision pathway is not panic. It is calibration. The studies suggest several specific levers that matter more for risk-allele carriers than for non-carriers.

First, get baseline values for glucose, lipids, and body composition now, so you have a personal trajectory to track. Second, focus on the eating-window and sleep findings: late meals, prolonged eating windows, and poor sleep amplify the diabetes risk specifically in A-allele carriers. Third, if your BMI is in the overweight or obese range and standard interventions are not working, this result helps make the case for more structured help, whether that means a registered dietitian, a metabolic specialist, or consideration of medication-assisted weight management.

If your result is TT, you have a genetic advantage. Standard cardiovascular and metabolic risk factors still apply. The FTO variant is one of dozens of genes that contribute to weight and metabolic risk, so this result lowers but does not eliminate your need for the same lifestyle attention everyone benefits from.